Maternal plasma P-selectin at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy

Hypertension in Pregnancy

Volumn 30, Issue 3, 2011, Pages 311-321

  Akolekar, Ranjit ^a   Veduta, Alina ^a   Minekawa, Ryoko ^a   Chelemen, Teodora ^a   Nicolaides, Kypros H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; P selectin; Preeclampsia; Uterine artery Doppler

Indexed keywords

PADGEM PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY DISORDER; SCREENING; UTERINE ARTERY;

ADULT; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; P-SELECTIN; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; PULSATILE FLOW; UTERINE ARTERY;

EID: 79960165930     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903242683     Document Type: Article

References (34)

1. WHO. Make Every Mother and Child Count. World Health Report, 2005. Geneva: World Health Organization, 2005.
2. Lewis G, ed. Why mothers die 2000-2002: The sixth report of confidential enquiries into maternal deaths in the United Kingdom. London: RCOG Press, 2004.
3. ACOG Committee on Practice Bulletins - Obstetrics. ACOG practice bulletin: diagnosis and management of preeclampsia and eclampsia: number 33, January 2002. Obstet Gynecol 2002; 99: 159-167.
4. Brosens I, Robertson WB, Dixon HG. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 1967; 93: 569-579.
5. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. BJOG 1986; 93:1049-1059. (Pubitemid 16004866)
6. Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. BJOG 1991; 98: 648-655.
7. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341:1447-1451. (Pubitemid 23161452)
8. Redman CWG. Pre-eclampsia and the placenta. Placenta 1991; 12:301-8.
9. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001; 38:718-722.
10. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on plasma membrane after activation. J Cell Biol 1985; 101:880-886. (Pubitemid 16256841)
11. Larsen E, Celi A, Gilbert GE, et al. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59:305-312. (Pubitemid 19264376)
12. Johnston GI, Bliss GA, Newman PJ, McEver RP. Structure of human gene encoding granule membrane protein-140 a member of selectin family of adhesion receptors for leukocytes. J Biol Chem 1990; 265:21381-21385. (Pubitemid 120014165)
13. Hamburger SA, McEver RP. GMP 140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75:550-554. (Pubitemid 20069190)
14. Geng JG, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343:757-750.
15. Holmes VA, Wallace JMW, Gilmore WS, McFaul P, Alexander HD. Soluble P-selectin levels during normal pregnancy: a longitudinal study. Br J Obstet Gynecol 2002; 109:997-1002. (Pubitemid 35279129)
16. Gerbasi FR, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 1990; 75:385-389. (Pubitemid 20062276)
17. Nisell H, Grunewald C, Berglud M, Karlberg KE, Lunell NO, Sylven C. Platelet aggregation in vitro and ex vivo in normal pregnancy, pregnancy induced hypertension and preeclampsia. Hypertens Pregnancy 1998; 17:147-155. (Pubitemid 28383043)
18. McCarthy AL, Woolfson RG, Raju SK, Poston L. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 1993; 168:1323-1330. (Pubitemid 23122189)
19. Whigham KAE. Abnormal platelet function in preeclampsia. Br J Obstet Gynecol 1978; 85:28-32.
20. Holthe MR, Staff AC, Berge LN, Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant and non-pregnant women. Am J Obstet Gynecol 2004; 190:1128-1134. (Pubitemid 38561536)
21. Norris LA, Sheppard BL, Burke G, Bonnar J. Platelet activation in normotensive and hypertensive pregnancies complicated by intrauterine growth restriction. Br J Obstet Gynecol 1994; 101:209-214. (Pubitemid 24197165)
22. Halim A, Kanayama N, Maradny EE, et al. Plasma P-selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances. Am J Obstet Gynecol 1996; 174: 272-277. (Pubitemid 26037723)
23. Heyl W, Handt S, Reister F, et al. Elevated soluble adhesion molecules in women with preeclampsia. Do cytokines like tumor necrosis factor-a and interleukin-1b cause endothelial activation? Eur J Obstet Gynecol Reprod Biol 1999; 86:35-41. (Pubitemid 29333247)
24. Aksoy H, Kumtepe Y, Akcay F, Yildirim AK. Correlation of P-selectin and lipoprotein (a), and other lipid parameters in preeclampsia. Clin Exp Med 2002; 2: 39-43. (Pubitemid 34743946)
25. Chaiworapongsa T, Romero R, Yoshimatsu J, et al. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonat Med 2002; 12: 19-27. (Pubitemid 34848424)
26. Chavarria ME, Lara-Gonzalez L, Garcia-Paleta Y, Vital-Reyes VS, Reyes A. Adhesion molecules change at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur J Obstet Gynecol Reprod Biol 2008; 137:157-164. (Pubitemid 351423464)
27. Banzola I, Farina A, Concu M, et al. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks gestation. Prenat Diagn 2007; 27:1005-1010. (Pubitemid 350114297)
28. Bosio PM, Cannon S, McKenna PJ, Herlihy CO, Conroy R, Brady H. Plasma P-selectin is elevated in the first trimester in women who subsequently develop preeclampsia. Br J Obstet Gynecol 2001; 108:709-715. (Pubitemid 32778277)
29. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 30:742-749. (Pubitemid 47612696)
30. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 31:618-624.
31. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352:343-346. (Pubitemid 28352196)
32. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:X-XIV.
33. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006; 113:580-589.
34. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with pre-eclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189:1173-1177. (Pubitemid 37373917)